文献速递骨肌技术与安全MR

全身MRI作为筛查工具排除多发性骨软骨瘤患者恶性进展是否有用?单中心319例成人队列研究结果

Is total-body MRI useful as a screening tool to rule out malignant progression in patients with multiple osteochondromas? Results in a single-center cohort of 319 adult patients.
PubMed 文献 · Skeletal Radiol · 2023-06-20

单中心319例遗传性多发性骨软骨瘤成人患者共366次全身MRI(含T1WI和STIR)回顾性分析,用于筛查或排除恶性转化。47例二次监测(平均间隔3.2年)未发现恶性病灶。

要点

  • 全身MRI可在遗传性多发性骨软骨瘤患者中识别骨软骨瘤恶性转化,本组9例外周软骨肉瘤均位于扁骨。
  • STIR高信号也可由反应性改变(摩擦性滑囊炎、软组织水肿)所致,22次靶向MRI未见可疑软骨帽。

核心结论

  • 全身MRI可识别遗传性多发性骨软骨瘤患者的骨软骨瘤恶性转化,本研究中所有外周软骨肉瘤均位于扁骨(肋骨、肩胛骨、骨盆);全身MRI可能有助于在高负荷骨软骨瘤(包括主要扁骨受累)的高风险患者与无扁骨骨软骨瘤的低风险患者之间进行分诊。

研究设计与样本

  • 单中心回顾性队列,纳入319例成人多发性骨软骨瘤患者,共366次全身MRI检查(含T1加权和STIR序列),用于筛查和随访以排除恶性转化;其中47例在本期间接受了第二次全身MRI监测。

关键影像表现/征象

  • 82%的患者在一个或多个扁骨中确定了一个或多个骨软骨瘤位置。
  • 9个恶性病灶均位于扁骨:骨盆5个、肋骨3个、肩胛骨1个。
  • 12例有外周或骨内低级别软骨肉瘤病史的患者在首次全身MRI前未发现新病灶。
  • 另23次全身MRI显示局灶性高T2信号,促使进行额外靶向MRI;股骨远端1个骨软骨瘤切除后为良性,其余22次靶向MRI未见可疑软骨帽,T2信号增高由与良性骨软骨瘤密切相关的反应性改变(摩擦性滑囊炎、软组织水肿)解释。

诊断标准与关键数值

  • 以STIR序列识别信号增高部位,代表可疑增厚软骨帽或与骨软骨瘤相关的 indeterminate 反应性改变。

临床应用与阅片要点

  • 全身MRI可用于遗传性多发性骨软骨瘤患者恶性转化的筛查或排除。
  • 阅片时需注意扁骨(骨盆、肋骨、肩胛骨)的骨软骨瘤位置,本组所有外周软骨肉瘤均位于扁骨。
  • STIR高信号需结合靶向MRI鉴别可疑软骨帽与反应性改变(摩擦性滑囊炎、软组织水肿)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the results of total-body (TB) MRI used as a screening tool for assessment or exclusion of malignant transformation in patients with hereditary multiple osteochondromas (HMO).

PATIENTS AND METHODS: In a single-institute cohort of MO patients, 366 TB-MRI examinations, including T1-weighted and STIR images, were performed for screening and follow-up purposes to rule out the malignant transformation, and retrospectively analyzed. In each patient, the presence and location of osteochondromas in the axial and appendicular bones were recorded. Forty-seven patients underwent a second TB surveillance in this period. STIR sequences were used to identify sites of increased signal intensity that could represent suspicious thickened cartilage caps or indeterminate reactive changes related to osteochondromas.

RESULTS: In 82% of patients, one or more OC locations were determined in one or more flat bones. In 366 exams, nine OC (2,5 %) with suspicious imaging features were identified. These proved to be peripheral chondrosarcomas after targeted MRI and resection were performed. All nine malignant lesions were in flat bones (pelvis 5, ribs 3, scapula 1). Three of these patients were 19 years of age. In 12 patients who had peripheral or intraosseous low-grade chondrosarcoma in their history, before their first TB-MRI, no new lesions were identified. Twenty-three additional TB-MRI exams, demonstrating focal high T2 signal intensity, also gave rise to performing additional targeted MRI. One OC of the distal femur was excised and appeared benign. No suspicious cartilage caps were depicted on the remaining 22 targeted MRI exams but instead increased T2 signal was clarified by reactive changes (frictional bursitis, soft tissue edema) in close relation with benign osteochondromas. No malignant lesions were found in 47 patients who had a second TB surveillance (mean interval between exams 3.2 years, range 2-5 years).

CONCLUSION: TB-MRI can identify malignant transformation of osteochondromas in HMO patients. All peripheral chondrosarcomas occurred in flat bones (ribs, scapula, pelvis) in our study. TB-MRI might assist in triage between higher risk patients with a high burden of OC, including the location of OC in main flat bones vs lower risk patients without OC of the flat bones.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Van der Woude, Flipsen, Welsink, et al. Is total-body MRI useful as a screening tool to rule out malignant progression in patients with multiple osteochondromas? Results in a single-center cohort of 319 adult patients. Skeletal Radiol. 2023. PMID: 37338590. doi:10.1007/s00256-023-04389-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。